SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001395064-21-000213
Filing Date
2021-10-25
Accepted
2021-10-25 06:07:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13G/A sc13ga_102521.htm SC 13G/A 64134
2 EX-99.1 exhibit991_102521.htm EX-99.1 1680
3 EX-99.2 exhibit992_102521.htm EX-99.2 9778
  Complete submission text file 0001395064-21-000213.txt   77103
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Subject) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91075 | Film No.: 211342086
SIC: 2834 Pharmaceutical Preparations